Goodwill of NOVAVAX INC from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
NOVAVAX INC quarterly Goodwill in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • NOVAVAX INC Goodwill for the quarter ending 30 Sep 2025 was $113,080,000, a 11% decline year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

NOVAVAX INC Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $113,080,000 -$13,686,000 -11% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $112,958,000 -$10,419,000 -8.4% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $112,027,000 -$11,152,000 -9.1% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $107,478,000 -$19,976,000 -16% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $126,766,000 +$2,986,000 +2.4% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $123,377,000 -$4,989,000 -3.9% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $123,179,000 -$6,648,000 -5.1% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $127,454,000 +$1,123,000 +0.89% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $123,780,000 +$6,245,000 +5.3% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $128,366,000 +$4,899,000 +4% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $129,827,000 -$929,000 -0.71% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $126,331,000 -$5,148,000 -3.9% 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $117,535,000 -$14,454,000 -11% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $123,467,000 -$10,827,000 -8.1% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $130,756,000 -$123,000 -0.09% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $131,479,000 -$3,900,000 -2.9% 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 $131,989,000 +$5,057,000 +4% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $134,294,000 +$15,445,000 +13% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $130,879,000 +$80,891,000 +162% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $135,379,000 +$84,225,000 +165% 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $126,932,000 +$76,627,000 +152% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $118,849,000 +$67,569,000 +132% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $49,988,000 -$1,257,000 -2.5% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $51,154,000 -$813,000 -1.6% 31 Dec 2019 10-K 01 Mar 2022 2021 FY
Q3 2019 $50,305,000 -$1,767,000 -3.4% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $51,280,000 -$703,000 -1.4% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $51,245,000 -$2,041,000 -3.8% 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 $51,967,000 -$1,596,000 -3% 31 Dec 2018 10-K 01 Mar 2021 2020 FY
Q3 2018 $52,072,000 -$1,674,000 -3.1% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $51,983,000 -$1,008,000 -1.9% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 $53,286,000 +$1,345,000 +2.6% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 $53,563,000 +$1,890,000 +3.7% 31 Dec 2017 10-K 11 Mar 2020 2019 FY
Q3 2017 $53,746,000 +$1,052,000 +2% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 $52,991,000 +$50,000 +0.09% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 $51,941,000 -$1,825,000 -3.4% 31 Mar 2017 10-Q 08 May 2017 2017 Q1
Q4 2016 $51,673,000 -$1,392,000 -2.6% 31 Dec 2016 10-K 18 Mar 2019 2018 FY
Q3 2016 $52,694,000 -$368,000 -0.69% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $52,941,000 -$366,000 -0.69% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 $53,766,000 +$1,102,000 +2.1% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 $53,065,000 -$1,547,000 -2.8% 31 Dec 2015 10-K 14 Mar 2018 2017 FY
Q3 2015 $53,062,000 -$3,112,000 -5.5% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 $53,307,000 -$4,599,000 -7.9% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 $52,664,000 -$5,957,000 -10% 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 $54,612,000 -$4,095,000 -7% 31 Dec 2014 10-K 27 Feb 2017 2016 FY
Q3 2014 $56,174,000 -$2,585,000 -4.4% 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 $57,906,000 +$24,765,000 +75% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 $58,621,000 +$25,480,000 +77% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 $58,707,000 +$25,566,000 +77% 31 Dec 2013 10-K 29 Feb 2016 2015 FY
Q3 2013 $58,759,000 +$25,618,000 +77% 30 Sep 2013 10-Q 06 Nov 2014 2014 Q3
Q2 2013 $33,141,000 $0 0% 30 Jun 2013 10-Q 07 Aug 2014 2014 Q2
Q1 2013 $33,141,000 $0 0% 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q4 2012 $33,141,000 $0 0% 31 Dec 2012 10-K 27 Feb 2015 2014 FY
Q3 2012 $33,141,000 $0 0% 30 Sep 2012 10-Q 12 Nov 2013 2013 Q3
Q2 2012 $33,141,000 $0 0% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 $33,141,000 31 Mar 2012 10-Q 09 May 2012 2012 Q1
Q4 2011 $33,141,000 $0 0% 31 Dec 2011 10-K 12 Mar 2014 2013 FY
Q3 2011 $33,141,000 30 Sep 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 $33,141,000 30 Jun 2011 10-Q 09 Aug 2011 2011 Q2
Q4 2010 $33,141,000 31 Dec 2010 10-K 14 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.